Eli Lilly halts diabetes trial of muscle-sparing drug with Zepbound - Bloomberg news

marketscreener
2025.09.25 10:40

9 月 25 日（路透社）- 禮來暫停了與 Zepbound 聯合進行的肌肉保護藥物糖尿病試驗 - 彭博新聞

Source: marketscreener The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.